Cargando…
Rituximab-Containing Risk-Adapted Treatment Strategy in Nodular Lymphocyte Predominant Hodgkin Lymphoma: 7-Years Follow-Up
SIMPLE SUMMARY: The current literature on NLPHL therapy is scarce due to the disease rarity. Our study aims to focus on the management and treatment strategies of NLPHL based on risk stratification. This paper contributes to the current literature, based mainly on retrospective studies and on small...
Autores principales: | Pugliese, Novella, Picardi, Marco, Della Pepa, Roberta, Giordano, Claudia, Muriano, Francesco, Leone, Aldo, Delle Cave, Giuseppe, D’Ambrosio, Alessandro, Marafioti, Violetta, Rascato, Maria Gabriella, Russo, Daniela, Mascolo, Massimo, Pane, Fabrizio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067750/ https://www.ncbi.nlm.nih.gov/pubmed/33917062 http://dx.doi.org/10.3390/cancers13081760 |
Ejemplares similares
-
Sulfur Exafluoride Contrast-Enhanced Ultrasound Showing Early Wash-Out of Marked Degree Identifies Lymphoma Invasion of Spleen with Excellent Diagnostic Accuracy: A Monocentric Study of 260 Splenic Nodules
por: Picardi, Marco, et al.
Publicado: (2022) -
Liposomal doxorubicin supercharge‐containing front‐line treatment in patients with advanced‐stage diffuse large B‐cell lymphoma or classical Hodgkin lymphoma: Preliminary results of a single‐centre phase II study
por: Picardi, Marco, et al.
Publicado: (2022) -
Correspondence in reference to the previously published Epub manuscript: “Murt Ahmet et al. Hepatitis B reactivation in hematopoietic stem cell transplanted patients: 20 years of experience of a single center from a middle endemic country. Annals of Hematology 2020; 99: 2671-2677”
por: Picardi, Marco, et al.
Publicado: (2021) -
Pegfilgrastim in primary prophylaxis of febrile neutropenia following frontline bendamustine plus rituximab treatment in patients with indolent non-Hodgkin lymphoma: a single center, real-life experience
por: Cerchione, Claudio, et al.
Publicado: (2016) -
Correspondence in reference to previously published manuscript: “Faouzi Djebbari et al. Efficacy and infection morbidity of front‐line immuno‐chemotherapy in follicular lymphoma. Eur J Haematol. 2020; 105: 667‐671”
por: Picardi, Marco, et al.
Publicado: (2021)